| Literature DB >> 34970593 |
Aruna Pal1, Abantika Pal2, Pradyumna Baviskar3.
Abstract
Avian influenza is a disease with every possibility to evolve as a human-to-human pandemic arising out of frequent mutations and genetic reassortment or recombination of avian influenza (AI) virus. The greatest concern is that till date, no satisfactory medicine or vaccines are available, leading to massive culling of poultry birds, causing huge economic loss and ban on export of chicken products, which emphasizes the need to develop an alternative strategy for control of AI. In the current study, we attempt to explore the molecular mechanism of innate immune potential of ducks against avian influenza. In the present study, we have characterized immune response molecules such as duck TLR3, TLR7, and RIGI that are predicted to have potent antiviral activities against the identified strain of avian influenza through in silico studies (molecular docking) followed by experimental validation with differential mRNA expression analysis. Future exploitation may include immunomodulation with the recombinant protein, and transgenic or gene-edited chicken resistant to bird flu.Entities:
Keywords: Anas platyrhynchos; RIGI; TLR3; TLR7; avian influenza
Year: 2021 PMID: 34970593 PMCID: PMC8712727 DOI: 10.3389/fmolb.2021.633283
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
List of primers used for amplification of TLR3, RIG1, and TLR7 genes in indigenous duck.
| Gene | Primer | Product length | Annealing temp |
|---|---|---|---|
| Primers used for amplification of TLR3 for duck | |||
| Duck TLR3.1 | FP: TGGAAAACAATGTCAAATCAG | 450 | 49.9 |
| RP: TCACGGAGGTTCTTCAG | |||
| Duck TLR3.2 | FP: TCCGTGAGCTTGTGTTGT | 460 | 50.2 |
| RP: AGATGTTTGAGCCTGGAC | |||
| Duck TLR3.3 | FP: GATAAATTCGCTCACTGG | 436 | 48.8 |
| RP: TCTAAGGCTTGGAACGA | |||
| Duck TLR3.4 | FP: TCAGCAATAACAACATAGCAAACA | 456 | 51.8 |
| RP: GGGTCGCATTAAGCCAACT | |||
| Duck TLR3.5 | FP: ATATACCTGGATTGCAGTCTCAGT | 650 | 52.7 |
| RP: CTGGGCTGGCCACTTCAAG | |||
| Primers used for amplification of RIG1 for duck | |||
| Duck RIG1.1 | FP: CTGCAGTGCTACCGCCGCTACATC | 460 | 59.6 |
| RP: TATCCGACCGACAGAGACATTCAA | |||
| Duck RIG1.2 | FP:AAAGATGTTGACAGTGAAATG | 402 | 50.8 |
| RP: TCCTTGAACAGAGTATCCTT | |||
| Duck RIG1.3 | FP: CAGGACGAAAGGCGAAAGTT | 448 | 53.8 |
| RP: TGTATGTCAAGGTAGGAGCAGAGA | |||
| Duck RIG1.4 | FP: ATCCCTTTGCAGCCATTATCC | 585 | 55.2 |
| RP: CGCGCCCCATCAAAACAC | |||
| Duck RIG1.5 | FP: TAACTACATAAAGCCAGGTG | 448 | 50.4 |
| RP: TACTTTAGGTTTTATTTCTTTC | |||
| Duck RIG1.6 | FP: CCAGAAGGAAAGAAATAAAACC | 416 | 52.3 |
| RP: TGGTGGGTACAAGTTGGACAT | |||
| Primers used for amplification of TLR7 of duck | |||
| Duck TLR7.1 | FP: TCAAGCATATTCATGAAGACTTT | 513 | 58.4 |
| RP: TGGGCCCCAACCTGACAG | |||
| Duck TLR7.2 | FP: TTGAGAATGGCAGTTTTG | 500 | 48.8 |
| RP: AGCCTTTGAATGTATCTTA | |||
| Duck TLR7.3 | FP: ACATTCAAAGGCTTTTTATTCCT | 754 | 52.4 |
| RP: TATTGCATTACCTGACAAGTTGAG | |||
| Duck TLR7.4 | FP: GATGCCTCAACTTGTCAGGTAATG | 751 | 53.5 |
| RP: TTTTCGGGGAAGCTAGATTTCTT | |||
| Duck TLR7.5 | FP: CTAGCTTCCCCGAAAATGTCAT | 736 | 54.8 |
| RP: TTCTGCACAGCCTTTTCCTCAG | |||
| Duck TLR7.6 | FP: AGCGCCTTCTAGATGAAAA | 400 | 48.8 |
| RP: TTTTAGTTTATGAGATTTTATTAT | |||
| List of primers used for QPCR study | |||
| β-Actin | FP: 5′-GAGAAATTGTGCGTGACATCA-3′ | 152 | 60 |
| RP: 5′-CCTGAACCTCTCATTGCCA-3′ | |||
| TLR2 | FP: 5′CATTCACCATGAGGCAGGGATAG-3′ | 157 | 60 |
| RP: 5′-GGTGCAGATCAAGGACACTAGGA-3′ | |||
| TLR4 | FP: 5′-TTCAGAACGGACTCTTGAGTGG-3′ | 131 | 60 |
| RP: 5′-CAACCGAATAGTGGTGACGTTG-3′ | |||
| TLR7 | 5′-TTGCTGCTGTTGTCTTGAGTGAG-3′ | 182 | 60 |
| 5′-AACAACAGTGCATTTGACGTCCT-3′ | |||
| | 5′-GGCTGTTGTGTCCTCACTCATCT-3′ | 106 | 60 |
| 5′-CACCACCGACATTGTTATTCCAT-3′ | |||
*The final and complete sequence is obtained by joining the fragments of the amplified products of the gene consecutively.
1TLR2, Toll-like receptor 2; TLR4, Toll-like receptor 4; TLR7, Toll-like receptor 7; Bu-1, chicken B-cell marker chB6.
FIGURE 1(A) TLR3 molecule of duck (secondary structure with disulphide bond) as blue sphere. (B) TLR3 molecule of duck (secondary structure with disulphide bond) surface view. (C) 3D structure of TLR3 of duck: yellow surface: leucine zipper (151–172), red sphere: GPI anchor (879), blue sphere: leucine-rich nuclear export signal, magenta sphere: LRRNT (37–51), orange sphere: LRRCT (664–687). (D) 3D structure of TLR3 of indigenous duck, blue sphere: TIR (748–890), orange mesh: leucine-rich receptor-like proteinkinase. (E) 3D structure of TLR3 of duck with leucine-rich repeat.
Amino acid variations for TLR3 gene in duck with other poultry species.
|
|
|
|
|
|
|
|
| 1 | 42 | K | E | K | K | LRRNT |
| 2 | 61 | H | L | H | H | LRR1 |
| 3 | 68 | C | V | V | C | LRR1 |
| 4 | 69 | H | P | P | P | LRR1 |
| 5 | 70 | A | E | E | A | LRR1 |
| 6 | 74 | R | Q | E | K | LRR1 |
| 7 | 77 | K | N | N | K | LRR2 |
| 8 | 92 | Q | K | Q | Q | LRR2 |
| 9 | 94 | E | O | E | E | LRR2 |
| 10 | 106 | V | K | K | V | LRR3 |
| 11 | 119 | A | V | V | T | LRR3 |
| 12 | 137 | D | E | E | D | LRR4 |
| 13 | 166 | L | L | L | W | LRR5 |
| 14 | 179 | C | Y | Y | C | LLR6 |
| 15 | 187 | K | N | K | K | LLR6 |
| 16 | 192 | S | K | K | S | LLR6 |
| 17 | 200 | N | N | N | K | LLR7 |
| 18 | 212 | F | V | F | F | LRR7 |
| 19 | 213 | H | Q | H | H | LRR7 |
| 20 | 285 | Y | S | S | S | LRR8 |
| 21 | 299 | N | K | N | N | LRR9 |
| 22 | 306 | K | E | E | K | LRR9 |
| 24 | 310 | S | I | I | I | LRR9 |
| 28 | 317 | S | L | L | S | LRR9 |
| 29 | 319 | Y | Y | Y | H | LRR9 |
| 30 | 346 | Y | H | Y | Y | LRR10 |
| 31 | 355 | N | N | H | N | LRR10 |
| 32 | 360 | R | R | Q | R | LRR10 |
| 33 | 370 | N | K | K | N | LRR11 |
| 34 | 378 | S | Y | Y | S | LRR11 |
| 35 | 382 | I | T | I | I | LRR11 |
| 36 | 390 | T | K | K | T | LRR11 |
| 37 | 423 | H | Q | Q | H | LRR12 |
| 38 | 435 | S | N | N | S | LRR12 |
| 39 | 444 | K | E | E | K | LRR12 |
| 40 | 468 | S | I | I | S | LRR13 |
| 41 | 497 | Q | R | R | Q | LRR14 |
| 42 | 521 | H | H | Y | H | LRR15 |
| 43 | 522 | K | E | K | K | LRR15 |
| 44 | 539 | H | C | Q | H | LRR15 |
| 45 | 571 | Q | H | H | Q | LRR |
| 46 | 577 | F | H | Q | F | LRR |
| 47 | 581 | Y | D | N | Y | LRR |
| 48 | 601 | T | T | N | T | LRR |
| 49 | 619 | E | N | D | V | LRR |
| 50 | 686 | V | A | A | A | LRRCT |
| 51 | 766 | I | T | T | I | TIR1 |
FIGURE 2(A) 3D structure of RIG1 of duck. (B) 3D structure of RIG1 of duck, surface view. (C) 3D structure of RIG1 of duck with sites for helicase insert domain, helicase domain interface (polypeptide binding). (D) 3D structure of RIG1 of duck depicting dsRNA binding site. (E) 3D structure of RIGI of duck with RD interface and RIG IC. (F) 3D structure of RIG1 of duck for zinc binding site. (G) 3D structure of RIG1 of duck of RNA binding site.
FIGURE 3(A) 3D structure of TLR7 of indigenous duck. (B) 3D structure of TLR7 of duck (surface view). (C) 3D structure of TLR7 of duck with the LRR region. (D) 3D structure for TLR7 of duck domains. (E) 3D structure of TLR7 of duck with LRRNT, TPKRC2, and GPI anchor. (F) Transmembrane helix for TLR7 of duck.
FIGURE 4Alignment/binding of identified immune response molecules with hemagglutinin and neuraminidase for different strains of avian influenza.
FIGURE 5Molecular docking of RIGI with surface antigen for avian influenza. (A) Molecular docking image RIG1 of duck with antigen (AI) ligand H antigen-binding site detection. (B) Molecular docking image RIG1 of duck with antigen (AI) NS antigen ligand (left) and binding site (right). (C) Duck RIGI model binding with H-antigen of avian influenza virus, with CARD domain—no binding for CARD with virus. (D) Duck RIGI model binding with N-antigen of avian influenza virus, with CARD domain—no binding for CARD with virus.
FIGURE 6(A) Molecular docking -TLR3 of duck with H antigen of Avian influenza (B) Molecular docking TLR3 of duck with NS antigen of Avian influenza.
FIGURE 7(A) Molecular docking TLR7 of duck with H antigen of avian influenza. (B) Molecular docking TLR7 of duck with NS antigen of avian influenza.
FIGURE 8(A) Alignment report for Haemagglutinin antigen for different strains for Avian influenza (B) Alignment report for Haemagglutinin antigen for different strains for Avian influenza by MAFFT software (MSA viewer) (C) Alignment report for neuraminidase antigen for different strains for Avian influenza (D) Alignment report for neuraminidase antigen for different strains for Avian influenza by MAFFT software (MSA viewer).
FIGURE 9(A) Comparison of TLR3 of duck and chicken-3D structural analysis (B) Comparison of TLR7 of duck and chicken-3D structural analysis.
FIGURE 10(A) String analysis revealing molecular interaction of TLR3 (B) String analysis revealing molecular interaction of TLR7.
FIGURE 11Differential mRNA expression profile of immune response genes of healthy duck with other poultry species.
FIGURE 12Differential mRNA expression profiling for TLR7 gene with respect to infected versus control Bengal duck and HB Chicken.
FIGURE 14Differential mRNA expression profiling for RIGI gene with respect to infected versus control Bengal duck and HB Chicken.
FIGURE 13Differential mRNA expression profiling for TLR3 with respect to infected versus control Bengal duck and HB Chicken.
FIGURE 15(A) Molecular evolution of ducks reared globally in relation to other poultry species (Based on TLR7) (B) Molecular evolution of ducks reared globally (Based on TLR3).